According to the FDA's official guidance (updated April 2026 at fda.gov), the semaglutide injection shortage was resolved on February 21, 2025, and the transitional exemption windows for compounders operating under the shortage exemption subsequently ended - for 503A pharmacies by April 22, 2025, and for 503B outsourcing facilities by May 22, 2025
However, by lowering blood glucose and reducing appetite, Semaglutide may mask some side effects of steroids, making it harder to notice steroid-related changes
Available in-person or via telehealth
What the progress tracker does Most weight-loss apps show you a single number on a single day
Compounding Pharmacy Specializing in Medical Weight Loss My Kaduceus is a compounding pharmacy offering personalized weight loss medications, including semaglutide, tirzepatide, and B12 lipotropic injections
These comprehensive evaluations are essential for establishing a clear, evidence-based understanding of the agents role in clinical practice